The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2022
Filed:
Aug. 08, 2018
Applicant:
Sanofi, Paris, FR;
Inventors:
Aimo Kannt, Frankfurt am Main, DE;
Maximilian Bielohuby, Frankfurt am Main, DE;
Ralf Elvert, Frankfurt am Main, DE;
Michael Wagner, Frankfurt am Main, DE;
Martin Bossart, Frankfurt am Main, DE;
Torsten Haack, Frankfurt am Main, DE;
Stephanie Keil, Frankfurt am Main, DE;
Werner Seiz, Frankfurt am Main, DE;
Assignee:
SANOFI, Paris, FR;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 45/06 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); C07K 14/605 (2006.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01); A61P 1/16 (2018.01); A61P 3/10 (2018.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01);
Abstract
The present invention relates to the medical use of specific GLP-1/glucagon receptor agonists in the prevention and/or treatment of metabolic liver disease, particularly non-alcoholic fatty liver disease (NAFLD), more particularly non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and/or NAFLD-associated liver fibrosis.